BRIEF-Intelgenx Technologies announces notice of appeal for Buprenorphine/Naloxone

Mon Jul 11, 2016 4:51pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

July 11 (Reuters) - Intelgenx Technologies Corp :

* Intelgenx announces notice of appeal for buprenorphine/naloxone sublingual film product for the treatment of opiate addiction

* Court ruled par's anda product would infringe asserted claims of u.s. Patent no. 8,603,514

* Court rule one of orange book listed patents for suboxone film, claims of u.s. Patent no. 8,603,514 were not shown to be invalid Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)